与马来西亚视网膜母细胞瘤患者死亡率相关的因素:一项回顾性队列研究
Z Nor-Aizura1,2, N Wan-Arfah3, N N Naing1
1Universiti Sultan Zainal Abidin, Faculty of Medicine, Kuala Terengganu, Terengganu, Malaysia.
The Medical journal of Malaysia
|December 25, 2025
概括
双边视网膜母细胞瘤和更长的诊断延迟是预测马来西亚儿童死亡率的关键因素. 早期检测和及时治疗对于改善视网膜母细胞瘤患者的生存率至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 儿科瘤学 儿科瘤学
- 流行病学 流行病学
背景情况:
- 视网母细胞瘤是全球最常见的眼内癌症.
- 关于东南亚视网膜母细胞瘤病例的死亡因素的研究有限.
- 这项研究解决了在马来西亚对视网膜母细胞瘤结局局部化数据的需求.
研究的目的:
- 确定预测马来西亚视网膜母细胞瘤患者死亡率的因素.
- 为改善该地区生存结果提供数据.
主要方法:
- 对402名视网膜母细胞瘤患者 (2004-2023) 的回顾性队列研究.
- 来自视网母细胞瘤注册表和医疗记录的数据.
- 多变量考克斯回归分析确定了死亡率的独立预测因素.
主要成果:
- 22名 (5.5%) 患者死亡;353名 (87.8%) 患者还活着.
- 双边视网膜母细胞瘤 (AHR:3.64) 和较长的延迟时间 (AHR:4.03) 是死亡率的独立预测因素.
- 侧面性,延迟时间和复发被确定为相关因素.
结论:
- 双边疾病和较长的诊断延迟独立预测马来西亚视网膜母细胞瘤死亡率较高.
- 强调早期诊断和及时治疗的关键需要.
- 这些发现可以为提高视网膜母细胞瘤生存率的策略提供信息.
相关概念视频
The Retinoblastoma Gene
4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Cancer Survival Analysis
624
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
624


